Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Coherus Oncology (CHRS) over the last 13 years, with Q3 2025 value amounting to $428.7 million.

  • Coherus Oncology's Total Liabilities fell 2769.57% to $428.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $428.7 million, marking a year-over-year decrease of 2769.57%. This contributed to the annual value of $580.5 million for FY2024, which is 2946.51% down from last year.
  • As of Q3 2025, Coherus Oncology's Total Liabilities stood at $428.7 million, which was down 2769.57% from $319.6 million recorded in Q2 2025.
  • Coherus Oncology's Total Liabilities' 5-year high stood at $845.4 million during Q1 2024, with a 5-year trough of $319.6 million in Q2 2025.
  • Moreover, its 5-year median value for Total Liabilities was $593.0 million (2024), whereas its average is $611.7 million.
  • In the last 5 years, Coherus Oncology's Total Liabilities skyrocketed by 8289.62% in 2021 and then plummeted by 5788.5% in 2025.
  • Over the past 5 years, Coherus Oncology's Total Liabilities (Quarter) stood at $581.6 million in 2021, then increased by 6.3% to $618.3 million in 2022, then surged by 33.12% to $823.0 million in 2023, then dropped by 29.47% to $580.5 million in 2024, then fell by 26.15% to $428.7 million in 2025.
  • Its Total Liabilities stands at $428.7 million for Q3 2025, versus $319.6 million for Q2 2025 and $554.5 million for Q1 2025.